Abstract
Liquid biopsy profiling is gaining increasing promise towards biomarker-led identification and disease stratification of tumours, particularly for tumours displaying significant intra-tumoural heterogeneity (ITH). For head and neck squamous cell carcinoma (HNSCC), which display high levels of genetic ITH, identification of epigenetic modifications and methylation signatures has shown multiple uses in stratification of HNSCC for prognosis, treatment, and HPV status. In this study, we investigated the potential of liquid biopsy methylomics and genomic copy number to profile HNSCC. We conducted multi-region sampling of tumour core, tumour margin and normal adjacent mucosa, as well as plasma cell-free DNA (cfDNA) across 9 HNSCC patients. Collectively, our work highlights the prevalence of methylomic ITH in HNSCC, and demonstrates the potential of cfDNA methylation as a tool for ITH assessment and serial sampling.
Original language | English |
---|---|
Article number | 107011 |
Journal | Oral Oncology |
Volume | 158 |
Early online date | 4 Sept 2024 |
DOIs | |
Publication status | E-pub ahead of print - 4 Sept 2024 |
Bibliographical note
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.Keywords
- Humans
- DNA Methylation
- Squamous Cell Carcinoma of Head and Neck/genetics
- Liquid Biopsy/methods
- Head and Neck Neoplasms/genetics
- DNA Copy Number Variations
- Cell-Free Nucleic Acids/genetics
- Male
- Female
- Middle Aged
- Aged
- Biomarkers, Tumor/genetics